Actively Recruiting

All Genders
ID06380192

Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

Led by Imagine Institute · Updated on 2025-06-29

400

Participants Needed

23

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Developmental and Epileptic Encephalopathies (DEE) are a diverse group of neurodevelopmental disorders associated with epilepsy and their underlying causes. Researchers aim to create a large national database with retrospective follow-up of many patients to better understand specific biomarkers. This will help improve classification and knowledge of DEE's natural progression depending on their causes, allowing for more personalized care and development of management recommendations where none currently exist. This observational study includes patients diagnosed with DEE and control patients undergoing routine EEG exams without epilepsy diagnoses. Data from 2002 to 2026 will be reused to identify diagnostic and early predictive biomarkers, categorize patient subgroups with these biomarkers, and assess quality of life, adaptive behavior, behavioral disorders, and autism spectrum disorders. The study uses existing clinical data without administering new treatments. Participants' data will be analyzed retrospectively to find markers linked to neurodevelopmental outcomes in DEE. The study will assess multiple aspects of patients' lives and behaviors over time. No new interventions or visits are required, as the study relies on existing health records. The trial runs until the end of 2026, with the goal to improve understanding and personalized management of DEE.

CONDITIONS

Brief Title

Developmental and Epileptic Encephalopathy of Genetic Etiology: Natural History Through Reuse of Clinical Data

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of Developmental and Epileptic Encephalopathy
  • Registered with or benefiting from a social security scheme
Not Eligible

You will not qualify if you...

  • Opposition of the patient or his/her parents to the re-use of data in the context of this study
  • Person subject to a safeguard of justice measure

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person or remote) to confirm eligibility and consent

Long-term Monitoring

Duration - Up to 24 years (from 2002 through 2026)

Participants’ clinical data and health outcomes are observed over time to understand the natural history of developmental and epileptic encephalopathies.

Data collected as part of routine healthcare visits and assessments

Trial Site Locations

Total: 23 locations

1

CHU Amiens

Amiens, France

Not Yet Recruiting

2

CH Angers

Angers, France

Not Yet Recruiting

3

Chu Besancon

Besançon, France

Not Yet Recruiting

4

CHU Bordeaux

Bordeaux, France

Not Yet Recruiting

5

CHRU Brest

Brest, France

Not Yet Recruiting

6

CHU Clermont-Ferrand

Clermont-Ferrand, France

Not Yet Recruiting

7

CHU Grenoble

Grenoble, France

Not Yet Recruiting

8

CHU Lille

Lille, France

Not Yet Recruiting

9

CHU Limoges

Limoges, France

Not Yet Recruiting

10

CHU Lyon HCL

Lyon, France

Not Yet Recruiting

11

Assistance Publique Hopitaux de Marseille

Marseille, France

Not Yet Recruiting

12

CHU de Nancy

Nancy, France

Not Yet Recruiting

13

Hopitaux Pediatriques de Nice CHU Lenval

Nice, France

Not Yet Recruiting

14

Necker-Enfants Malades Hospital

Paris, France, 75015

Actively Recruiting

15

CHU Pitié Salpétrière

Paris, France

Not Yet Recruiting

16

CHU Robert Debré

Paris, France

Not Yet Recruiting

17

Hôpital Armand Trousseau

Paris, France

Not Yet Recruiting

18

Chu Reims

Reims, France

Not Yet Recruiting

19

CHU Rennes

Rennes, France

Not Yet Recruiting

20

CHU Strasbourg

Strasbourg, France

Not Yet Recruiting

21

CHU Toulouse

Toulouse, France

Not Yet Recruiting

22

CHRU Tours

Tours, France

Not Yet Recruiting

23

Hôpital André Mignot (CH Versailles)

Versailles, France

Not Yet Recruiting

Loading map...

Research Team

R

Rima Nabbout, Pr

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Mul...

Developmental and Epileptic Encephalopathy

Actively Recruiting

110 locations

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here